AccessPak for HIV PEP Expanded with Kaletra and Tranylcypromine
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Tranylcypromine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: tranylcypromine
Brand name: Parnate
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Tranylcypromine Sulfate
- AccessPak for HIV PEP Expanded with Kaletra-Tranzarel Gel
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab and Hyaluronidase
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab Injection (Intravenous)
- AccessPak for HIV PEP Expanded with Kaletra-Trastuzumab Intravenous
- Tranylcypromine-AccessPak for HIV PEP Expanded with Viracept
- Tranylcypromine-Accolate
- Tranylcypromine-Accretropin
- Tranylcypromine-Accucaine
- Tranylcypromine-AccuHist Drops
- Tranylcypromine-AccuHist PDX Drops